G antigen 2E (GAGE2E)

G antigen 2E (GAGE2E) is a cancer/testis antigen belonging to the GAGE family, characterized by expression in various tumors and restricted expression in normal tissues except for the testis and stomach[1][2][4]. The precise biological function is not well defined, but like other GAGE proteins, it may be involved in immune recognition of tumor cells—these proteins can be recognized by cytolytic T lymphocytes due to their presentation of immunogenic peptides[4]. GAGE2E is associated with neoplastic diseases, particularly rectosigmoid junction neoplasm, and is part of a gene family highly relevant in cancer immunology research[2][4]. No drugs are currently approved targeting GAGE2E specifically, but as a cancer/testis antigen, it is considered a potential target for immunotherapeutic strategies and may serve as a tumor biomarker[2][4].

Other names

GAGE2EG antigen 2EGAGE-2EGAGE8GAGE-12BG antigen 12B/C/D/EGAGE12B[2][4][5][7][8]

Not defined (therapeutic mechanism would likely be immune-mediated via recognition as a cancer/testis antigen, but no approved drugs or therapies targeting GAGE2E directly)[4]